Mark J Abzug

Summary

Publications

  1. doi request reprint Acute sinusitis in children: do antibiotics have any role?
    Mark J Abzug
    University of Colorado School of Medicine and Children s Hospital Colorado, Pediatric Infectious Diseases, Box B055, 13123 East 16th Avenue, Aurora, CO 80045, USA Electronic address
    J Infect 68:S33-7. 2014
  2. doi request reprint The enteroviruses: problems in need of treatments
    Mark J Abzug
    University of Colorado School of Medicine and Children s Hospital Colorado, Pediatric Infectious Diseases, Box B055, 13123 East 16th Avenue, Aurora, CO 80045, USA Electronic address
    J Infect 68:S108-14. 2014
  3. pmc Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    Pediatric Infectious Diseases, Box B055, Children s Hospital Colorado, 13123 East 16th Ave, Aurora, CO 80045, USA
    J Infect Dis 206:512-22. 2012
  4. pmc Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy
    Mark J Abzug
    Department of Pediatrics Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, CO, USA Electronic address
    Vaccine 31:4782-90. 2013
  5. pmc Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women
    Mark J Abzug
    Department of Pediatrics, Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, CO, USA
    Clin Infect Dis 56:1488-97. 2013
  6. pmc Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado Denver School of Medicine and The Children s Hospital, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Infect Dis 200:935-46. 2009
  7. pmc Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents
    Paul Krogstad
    aDepartment of Pediatrics Infectious Diseases bDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California cDepartment of Epidemiology, Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts dEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland eUniversity of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado fDepartment of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey gNew York University School of Medicine hAlbert Einstein College of Medicine, New York City, New York, USA iDepartment of Pediatrics, Federal University of Minas Gerais, Minas Gerais, Brazil jTulane University School of Medicine, New Orleans, Louisiana, USA
    AIDS 29:683-93. 2015
  8. ncbi request reprint Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature
    Jill H Simmons
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:234-8. 2005
  9. pmc Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
    David W Kimberlin
    Department of Pediatrics, University of Alabama at Birmingham, AL 35233, USA
    J Infect Dis 207:709-20. 2013
  10. ncbi request reprint Presentation, diagnosis, and management of enterovirus infections in neonates
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine and The Children s Hospital, Denver, Colorado 80218, USA
    Paediatr Drugs 6:1-10. 2004

Collaborators

Detail Information

Publications15

  1. doi request reprint Acute sinusitis in children: do antibiotics have any role?
    Mark J Abzug
    University of Colorado School of Medicine and Children s Hospital Colorado, Pediatric Infectious Diseases, Box B055, 13123 East 16th Avenue, Aurora, CO 80045, USA Electronic address
    J Infect 68:S33-7. 2014
    ..The most compelling rationale is prevention of serious complications, but proof for this rationale is lacking. ..
  2. doi request reprint The enteroviruses: problems in need of treatments
    Mark J Abzug
    University of Colorado School of Medicine and Children s Hospital Colorado, Pediatric Infectious Diseases, Box B055, 13123 East 16th Avenue, Aurora, CO 80045, USA Electronic address
    J Infect 68:S108-14. 2014
    ..The three conditions described illustrate why development of antiviral medications for EV infections is a medically important need...
  3. pmc Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    Pediatric Infectious Diseases, Box B055, Children s Hospital Colorado, 13123 East 16th Ave, Aurora, CO 80045, USA
    J Infect Dis 206:512-22. 2012
    ..Response rates and immunologic memory following measles vaccination are reduced in human immunodeficiency virus (HIV)-infected children in the absence of highly active antiretroviral therapy (HAART)...
  4. pmc Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy
    Mark J Abzug
    Department of Pediatrics Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, CO, USA Electronic address
    Vaccine 31:4782-90. 2013
    ..The capacity of pneumococcal vaccination to confer memory in HIV-infected children is critical for durable protection...
  5. pmc Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women
    Mark J Abzug
    Department of Pediatrics, Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, CO, USA
    Clin Infect Dis 56:1488-97. 2013
    ..The safety and immunogenicity of pH1N1 vaccination in HIV-infected pregnant women are unknown...
  6. pmc Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado Denver School of Medicine and The Children s Hospital, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Infect Dis 200:935-46. 2009
    ..The immunogenicity of HBV vaccination in children receiving highly active antiretroviral therapy (HAART) was investigated...
  7. pmc Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents
    Paul Krogstad
    aDepartment of Pediatrics Infectious Diseases bDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California cDepartment of Epidemiology, Center for Biostatistics in AIDS Research CBAR, Harvard School of Public Health, Boston, Massachusetts dEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland eUniversity of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado fDepartment of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey gNew York University School of Medicine hAlbert Einstein College of Medicine, New York City, New York, USA iDepartment of Pediatrics, Federal University of Minas Gerais, Minas Gerais, Brazil jTulane University School of Medicine, New Orleans, Louisiana, USA
    AIDS 29:683-93. 2015
    ..The frequency, severity and significance of these discordant treatment responses remain unclear...
  8. ncbi request reprint Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature
    Jill H Simmons
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:234-8. 2005
    ..To illustrate that rapid diagnosis and aggressive treatment of rhinocerebral mucormycosis with internal carotid artery occlusion in a pediatric patient can prevent mortality and significant morbidity...
  9. pmc Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
    David W Kimberlin
    Department of Pediatrics, University of Alabama at Birmingham, AL 35233, USA
    J Infect Dis 207:709-20. 2013
    ..Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown...
  10. ncbi request reprint Presentation, diagnosis, and management of enterovirus infections in neonates
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine and The Children s Hospital, Denver, Colorado 80218, USA
    Paediatr Drugs 6:1-10. 2004
    ..Limited pharmacokinetic data are available in infants and neonates. A multicenter, placebo-controlled, randomized trial of pleconaril in neonates with severe hepatitis, coagulopathy, and/or myocarditis is currently being conducted...
  11. pmc Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment
    Paige L Williams
    aCenter for Biostatistics in AIDS Research bDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts cDepartment of Pediatrics Infectious Diseases, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado dTulane University School of Medicine, New Orleans, Louisiana eEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland fDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts gSection of Pediatric Endocrinology, Indiana University School of Medicine, Indianapolis, Indiana hDepartment of Pediatrics, University of Colorado School of Medicine, Denver, Colorado iNew York University School of Medicine, New York jDepartment of Pediatrics, New Jersey Medical School, Newark, New Jersey kSaban Research Institute, Children s Hospital Los Angeles, Los Angeles, California, USA
    AIDS 27:1959-70. 2013
    ..To evaluate associations of perinatal HIV infection, HIV disease severity, and combination antiretroviral treatment with age at pubertal onset...
  12. ncbi request reprint Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children
    Mark J Abzug
    University of Colorado School of Medicine and The Children s Hospital Pediatric Infectious Diseases, Department of Pediatrics, Denver, CO 80218, USA
    Pediatr Infect Dis J 23:769-73. 2004
    ..Adjunctive therapy with interferon-gamma, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor can be considered for refractory invasive fungal infections...
  13. pmc Safety of oseltamivir compared with the adamantanes in children less than 12 months of age
    David W Kimberlin
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama, Birmingham, Birmingham, AL 35233, USA
    Pediatr Infect Dis J 29:195-8. 2010
    ..To assess potential neurologic adverse effects of oseltamivir use in infants, a retrospective chart review was performed in infants less than 12 months of age who received oseltamivir, amantadine, or rimantadine...
  14. ncbi request reprint The enteroviruses: an emerging infectious disease? The real, the speculative and the really speculative
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine, The Children s Hospital, Denver, CO 80218, USA
    Adv Exp Med Biol 609:1-15. 2008
  15. ncbi request reprint Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
    Mark J Abzug
    Pediatric Infectious Disease, Department of Pediatrics, University of Colorado School of Medicine and The Children s Hospital, 1056 E Nineteenth Avenue, Denver, CO 80218, USA
    Pediatr Infect Dis J 22:335-41. 2003
    ..Treatment of older children and adults with pleconaril has been associated with reduced severity and duration of symptoms. This study evaluated the pharmacokinetics, safety and efficacy of pleconaril in infants with EV meningitis...